Patents/Assignees

PEMI31 Therapeutics Inc.

1 patent in portfolio

US12005101utility2024
Modulation of Proprotein Convertase Subtilisin/kexin 9 Expression (PCSK9) with HSP 27 And/or HSP25
0 cites